Differences in transport function of the human and rat orthologue of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1).


Journal

Drug metabolism and pharmacokinetics
ISSN: 1880-0920
Titre abrégé: Drug Metab Pharmacokinet
Pays: England
ID NLM: 101164773

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 07 04 2021
revised: 30 06 2021
accepted: 17 08 2021
pubmed: 11 10 2021
medline: 14 1 2022
entrez: 10 10 2021
Statut: ppublish

Résumé

The human drug transporter Organic Anion Transporting Polypeptide (hOATP)2B1 facilitates cellular uptake of its substrates. Various studies suggest that hOATP2B1 is involved in intestinal absorption, but preclinical evaluations performed in rodents do not support this. Thus, our study aimed to compare the expression and function of hOATP2B1 with its orthologue in rats (rOatp2b1). Even if the general expression pattern was comparable, the transporters exhibited substantial differences on functional level. While bromosulfophthalein and atorvastatin were substrates of both transporters, the steroid sulfate conjugates estrone 3-sulfate (E

Identifiants

pubmed: 34628357
pii: S1347-4367(21)00039-2
doi: 10.1016/j.dmpk.2021.100418
pii:
doi:

Substances chimiques

Organic Anion Transporters 0
oatp2b1 protein, rat 0
Estrone 2DI9HA706A
Atorvastatin A0JWA85V8F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100418

Informations de copyright

Copyright © 2021 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the authors have a conflict of interest to declare.

Auteurs

Janine Hussner (J)

Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Annalise Foletti (A)

Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Isabell Seibert (I)

Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Anja Fuchs (A)

Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Eveline Schuler (E)

Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Vanessa Malagnino (V)

Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Markus Grube (M)

Institute of Pharmacology, C_DAT Center of Drug Absorption and Transport, University Medicine Greifswald, Greifswald, Germany.

Henriette E Meyer Zu Schwabedissen (HE)

Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Electronic address: h.meyerzuschwabedissen@unibas.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH